Diagnostyka SA (DIA)
DIA · Health Care · 
Poland
Diagnostyka SA (DIA) is a company in the Health Care sector, based in Poland. The stock is held in 1 ETF we track. Anyone holding one of these ETFs also owns a small indirect stake in Diagnostyka.
How many funds hold this stock?
Low ETF coverage: 1 of the 95 ETFs we cover holds Diagnostyka, spread across one index. That places it among the least widely held names in index funds — of the 4,334 stocks we cover, none sits in fewer ETFs.
The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.
What ETF is Diagnostyka in?
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| IS3N | msci-em-imi | 0.00 % | €0.00 |
The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Diagnostyka as of the fund's latest holdings list.
How much Diagnostyka SA overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Diagnostyka — the figure counts the ETFs holding both.
| Stock | Ticker | Shared ETFs | r |
|---|---|---|---|
| Shandong Weigao GP Medical Polymer | 1066 | 1 | – |
| Hanmi Pharm Ltd. | 128940 | 1 | – |
| Liga Chem Bio Inc. | 141080 | 1 | – |
| Jinxin Fertility Group | 1951 | 1 | – |
| Ssy Group Ltd. | 2005 | 1 | – |
| Saudi Pharmaceutical Indust and Me | 2070 | 1 | – |
| Microport Neurotech Corp. | 2172 | 1 | – |
| Luye Pharma Group | 2186 | 1 | – |
